Risk Factors for Thyroid Cancer in Systemic Lupus Erythematosus
We studied 3 patients with systemic lupus erythematosus (SLE) who developed thyroid cancer (TC). Potential risk factors for TC development was explored. Fifty-three patients with a clinical diagnosis of rheumatic diseases including SLE at our hospital between July 2014 and December 2014 were enrolle...
Saved in:
Main Authors: | Yutaka Kawano MD, PhD (Author), Meika Nambu MD (Author), Youji Uejima MD (Author), Satoshi Sato MD, PhD (Author), Eisuke Suganuma MD, PhD (Author), Tadamasa Takano MD, PhD (Author), Tsutomu Oh-ishi MD, PhD (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2017-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chilblain lupus erythematosus associated with erdafitinib therapy in a patient with metastatic bladder cancer
by: Amanda Truong, MD, PhD, et al.
Published: (2024) -
P53 and Granzyme B may have a role in progression to malignancy in hypertrophic discoid lupus erythematosus
by: Leticia da Silva Valandro, MD, et al.
Published: (2022) -
Polyautoimmunity in patients with cutaneous lupus erythematosus: A nationwide sex- and age-matched cohort study from Denmark
by: Christoffer S. Graven-Nielsen, et al.
Published: (2023) -
Periorbital discoid lupus erythematosus: A retrospective study
by: Erin Theisen, MD, PhD, et al.
Published: (2022) -
Anifrolumab for the treatment of refractory chilblain lupus erythematosus
by: Michael J. Woodbury, BS, et al.
Published: (2024)